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Sox2 regulates the self-renewal of multiple types of
stem cells. Recent studies suggest it also plays
oncogenic roles in the formation of squamous carci-
noma in several organs, including the esophagus
where Sox2 is predominantly expressed in the basal
progenitor cells of the stratified epithelium. Here, we
use mouse genetic models to reveal a mechanism by
which Sox2 cooperates with microenvironmental
signals to malignantly transform epithelial progenitor
cells. Conditional overexpression of Sox2 in basal
cells expands the progenitor population in both the
esophagus and forestomach. Significantly, carci-
noma only develops in the forestomach, where path-
ological progression correlates with inflammation
and nuclear localization of Stat3 in progenitor cells.
Importantly, co-overexpression of Sox2 and acti-
vated Stat3 (Stat3C) also transforms esophageal
basal cells but not the differentiated suprabasal cells.
These findings indicate that basal stem/progenitor
cells are the cells of origin of squamous carcinoma
and that cooperation between Sox2 and microenvi-
ronment-activated Stat3 is required for Sox2-driven
tumorigenesis.
INTRODUCTION
Stem/progenitor cells are important for maintaining tissue
homeostasis, and their aberrant regulation contributes to tumor
initiation and cancer progression (Barker et al., 2009; Schepers304 Cell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc.et al., 2012). This suggests that signaling molecules and tran-
scription factors such as Sox2, which are important for stem
cell maintenance, need to be strictly regulated. Recently,
genomic studies have shown that abnormal levels of Sox2
correlate with squamous cell carcinoma (SCC) in the lung
and esophagus (Bass et al., 2009; Gen et al., 2010). However,
the mechanisms underlying this association remain largely
unexplored.
Sox2 plays a critical role in maintaining embryonic stem cells
as well as adult stem cells in multiple tissues (Arnold et al.,
2011; Avilion et al., 2003; Masui et al., 2007; Que et al., 2009;
Sarkar and Hochedlinger, 2013). Sox2 is also required for the
self-renewal of cancer stem cells (also known as tumor initiating
cells) in several malignancies, including glioblastoma and breast
cancer (Gangemi et al., 2009; Leis et al., 2012). Moreover,
recently Sox2 has been identified as a direct target of Myeloid
Elf-1-like factor (MEF, also known as ELF4) in glioblastoma
cancer stem cells, and Sox2 overexpression could rescue the
decrease in neurosphere formation seen in cells lacking MEF
(Bazzoli et al., 2012). We previously demonstrated that Sox2
regulates the proliferation and differentiation of epithelial
progenitor cells in the developing mouse esophagus and forest-
omach, which are both lined by a similar stratified keratinized
epithelium (Que et al., 2007). In the adult, Sox2 is predominantly
expressed in all of the basal progenitor cells in these tissues (this
study and Arnold et al., 2011). Intriguingly, recent clinical studies
have revealed that SOX2 gene amplification and protein overex-
pression frequently occur in SCC of human foregut-derived
tissues including the lung and esophagus (Bass et al., 2009;
Gen et al., 2010). Conditional Sox2 overexpression in adult
mouse lung epithelium leads to tumor formation in one study
(Lu et al., 2010). In another study, Sox2 overexpression in the
same cell population results in hyperplasia but not tumor forma-
tion, and the reason for this discrepancy remains undetermined
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Figure 1. Sox2-Positive Basal Progenitor
Cells Self-Renew and Differentiate In Vitro
and In Vivo
(A) Sox2 and Loricrin are expressed in the basal
and suprabasal layers of the stratified epithelium,
respectively. Nuclei are counterstained with DAPI.
(B) Krt5 and p63 are also expressed in the basal
cells.
(C) Proliferating (Ki67+) cells are limited to the
basal layer, labeled by p75 (nerve growth factor
receptor).
(D) Isolated basal progenitor cells proliferate to
formcolonies andmaintain the expression of Sox2.
(E) Schematic of the 3D culture system in which
single p75-positive basal cells are embedded and
grown in matrix.
(F) Single basal cells proliferate to form esoph-
ageospheres and maintain high levels of Sox2
expression in serum-free medium after being
cultured for 8 days.
(G) Cells inside the sphere differentiate into
squamous epithelium (Loricrin+) in the presence
of 5% fetal bovine serum.
(H) A single low dose of Tamoxifen (0.1 mg/g body
weight) labels individual cells in the basal layer of
the KRT5-CreER;Rosa26-lacZ esophagus 14 hr
after injection (left). Labeled basal cells divide
and remain in basal layer (middle) and daughter
cells differentiate and migrate upward (right) 72 hr
after injection.
(I) Similarly, KRT5-CreER labels individual basal progenitor cells in the forestomach with a low dose of Tamoxifen.
(J) Three doses of Tamoxifen (0.25 mg/g body weight) induce genetic recombination in 75% and 56% epithelial cells of the KRT5-CreER;Rosa26-lacZ
esophagus and forestomach, respectively (n = 3). Abbreviations: Lor, Loricrin; Krt, Keratin; Tmx, Tamoxifen. Scale bar represents 50 mm. See also Figure S1.
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Sox2 and Stat3 Cotransform Foregut Progenitors(Tompkins et al., 2011). In other important studies using human
immortalized airway epithelial cells, SOX2 overexpression alone
is insufficient to drive transformation, and this outcome requires
co-overexpression of additional genes such as FoxE1 or FgfR2
IIIb (Bass et al., 2009). Therefore, synergistic cooperation
between multiple genes/pathways appears to be required for
SOX2 overexpression to drive tumor initiation. However, how
the cooperation is executed in an in vivo setting and whether
the oncogenic role of Sox2 is specific for stem/progenitor cells
has yet to be determined.
Inflammation is frequently observed in human esophageal
SCC biopsies and facilitates tumor formation in the esophagus
and forestomach of animal models (Stairs et al., 2011; Taccioli
et al., 2012). However, the mechanism by which inflammation
promotes tumor initiation in these tissues remains elusive.
Tissue-specific overexpression of the inflammatory factor IL-1b
in the glandular mouse hindstomach induces severe inflamma-
tion, with increased levels of IL-6, and promotes adenocarci-
noma in this region through the activation of both the Stat3
and NF-kB pathways (Tu et al., 2008). In addition, deletion of
the intercellular adhesion molecule p120-catenin disrupts
epithelial integrity and leads to SCC in the forestomach. The
pathological progression of the SCC is also accompanied by
the accumulation of inflammatory cells and increased nuclear
localization of phosphorylated Stat3 (p-Stat3) in tumor cells
(Stairs et al., 2011), but how this increased Stat3 activation is
involved in SCC formation has not been determined.
Here, we use mouse models in combination with in vitro
assays to investigate themechanism bywhich Sox2 overexpres-Csion drives SCC formation. We show that conditional Sox2 over-
expression increases proliferation and inhibits differentiation of
basal progenitor cells in the stratified epithelium. Nevertheless,
Sox2 overexpression alone is insufficient for driving SCC
formation. Rather, this outcome is associated withmicroenviron-
ment-activated Stat3, which cooperates with Sox2 to drive
malignant transformation of progenitor cells.
RESULTS
Sox2- and Krt5-Positive Basal Progenitor Cells Both
Self-Renew and Differentiate In Vitro and In Vivo
We demonstrated previously that Sox2 is required for the devel-
opment of the stratified epithelium of the mouse esophagus and
forestomach (Jacobs et al., 2012; Que et al., 2007). In the adult,
Sox2 is expressed prominently in the basal layer of these two
tissues (Figures 1A and 2E) (Arnold et al., 2011). All of these cells
also express the intermediate filaments Keratin 5 (Krt5) and
Keratin 14 (Krt14) (data not shown), as well as p63 (Figure 1B),
a transcription factor important for epithelial stratification
(Wang et al., 2011). Ki67 immunostaining indicates that these
basal cells are highly proliferative compared to nondividing
suprabasal cells (Figure 1C). When purified by fluorescence-
activated cell sorting (FACS) with the basal cell surface marker
p75 (nerve growth factor receptor [NgfR], Figure 1C) and
cultured in the presence of 20 ng/ml Fgf2 and Egf, Sox2+ve
basal cells maintain self-renewal capability and form large colo-
nies with a colony-forming efficiency of 4% (Figure 1D). In addi-
tion, isolated single basal cells proliferate to form organoidsell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc. 305
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Figure 2. Sox2 Overexpression Promotes Self-Renewal and Inhibits the Differentiation of Basal Progenitor Cells
(A) Schematic for the generation of KRT5-CreER;Rosa26Sox2/Sox2 (KRT5-CreER;R26Sox2/Sox2) compound mutants. The CAG promoter is a combination of the
cytomegalovirus (CMV) early enhancer element and chicken beta-actin promoter.
(B) Three doses of Tamoxifen induce Sox2 overexpression in the esophagus and forestomach as indicated by GFP expression.
(C) Sox2 overexpression leads to epithelial hyperplasia in the esophagus and forestomach as shown by hematoxylin and eosin (H&E) immunohistochemistry.
(D) Sox2 overexpression expands p63+ve progenitor cell populations in the esophagus and forestomach.
(E) Sox2 overexpression leads to increased cell proliferation as indicated by phosphorylated Histone H3 (arrowheads). Note that proliferating cells are present in
the surface layer (arrows). The corner insert is a higher magnification of the boxed region.
(F) Sox2 overexpression inhibits the differentiation of basal progenitor cells in the esophagus and forestomach. Note that in the mutants the presence of patches
of epithelial cells negative for the differentiation marker Loricrin. Refer to Figure S1F for individual fluorescent channels. Abbreviations: Fst, forestomach; Hst,
hindstomach; Ep, epithelium; Me, mesenchyme. Scale bar represents 50 mm. See also Figure S1.
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Sox2 and Stat3 Cotransform Foregut Progenitors(esophageospheres) when embedded in extracellular matrix in
a three-dimensional (3D) culture system (Figure 1E). Consistent
with these findings, only FACS-sorted GFP-positive epithelial
cells from the esophagus of a Sox2GFP ‘‘knockin’’ mouse line
form esophageospheres (see Figure S1A available online). In
the absence of serum, basal cells self-renew to form solid
spheres in which 95% of the cells maintain high levels of
Sox2 protein (Figure 1F). When dissociated and reseeded under
the same culture conditions, single progenitor cells can reform
spheres for four passages (data not shown). By contrast, the
addition of 5% serum to the sphere culture induces the differen-
tiation of cells in the center toward a Loricrin+ve squamous cell
fate, while Sox2+ve cells are confined to the periphery (Fig-306 Cell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc.ure 1G). This demonstrates that adult Sox2+ve basal cells are
progenitors that both self-renew and differentiate in vitro.
To test whether Sox2+ve basal cells can self-renew and differ-
entiate in vivo, we exploited a KRT5-CreER transgenic mouse
line to perform lineage tracing in combination with the Rosa26-
lacZ reporter allele (Jovov et al., 2011; Rock et al., 2009). By
using a low dose of Tamoxifen to label individual basal cells in
the esophagus and following their behavior for 3 days, we
found that single cells can divide to duplicate themselves
and also differentiate to form columns of squamous epithelium
(Figure 1H). Similar results were observed in the forestomach
(Figure 1I). These findings are consistent with previous lineage-
tracing results using the Sox2-CreER mouse line (Arnold et al.,
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Figure 3. Sox2 Overexpression Leads to the Development of Inva-
sive Squamous Cancer in the Forestomach
(A and B) Tumors are formed in the forestomach but not the esophagus at
3 months after Sox2 induction with two doses of Tamoxifen. (B) is a magnified
view of the stomach in (A).
(C and D) Tumor mass is positive for GFP (included in the Sox2 overexpression
construct) (D). No fluorescent signal is observed in the non-Sox2 over-
expression control (C).
(E and F) Well-organized stratified epithelium, mesenchyme, andmuscle in the
forestomach of the wild-type control (E), and cancer cells invade into the
muscle layer as shown by H&E staining (F).
(G and H) In the normal forestomach, the basal cell marker p63 is expressed in
the basal layer (G), and cancer cells in the mutant forestomach are positive for
p63 (H). Inserts are high magnification of the boxed region in the sections.
Abbreviations: Eso, esophagus; Fst, forestomach; Hst, hindstomach; Duo,
duodenum; Ep, epithelium; Me, mesenchyme; Mu, muscle. Scale bar repre-
sents 50 mm. See also Table S1.
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Sox2 and Stat3 Cotransform Foregut Progenitors2011) and recent in vivo lineage-tracing data (Doupe´ et al., 2012).
In addition, three injections with a higher dose of Tamoxifen
gave genetic recombination in 75% and 56% of basal cells
in the esophagus and forestomach, respectively (n = 3, Fig-Cure 1J), showing that the KRT5-CreER allele is an efficient tool
for genetic manipulation of the basal progenitor cell population
in these tissues.
Conditional Overexpression of Sox2 Results in Basal
Progenitor Cell Hyperplasia in Both the Esophagus and
SCC in the Forestomach
SOX2 overexpression has been implicated in the formation of
esophageal SCC (Bass et al., 2009; Gen et al., 2010). To directly
test the oncogenic potential of Sox2 in vivo, we generated KRT5-
CreER;Rosa26CAG-loxp-stop-loxp-Sox2-IRES-Egfp compound mutants
(hereafter referred to as KRT5-CreER;Rosa26Sox2) in which
Sox2 is overexpressed in basal progenitor cells and their deriva-
tives after Tamoxifen injection (Figure 2A). The conditional
Rosa26Sox2 allele contains IRES-eGFP, which serves as an indi-
cator for Sox2 overexpression at the cellular level (Figures 2A
and 2B). Three injections with Tamoxifen (0.25 mg/g body
weight) result in Sox2 overexpression in 71% and 63% of basal
cells in the esophagus and forestomach, respectively, with an
insignificant difference between the esophagus and forestom-
ach (p > 0.05). The Sox2 protein levels in the Sox2-overexpress-
ing progenitor cells (GFP+ve) isolated from both the esophagus
and forestomach are comparable but apparently higher than
wild-type basal progenitor cells (Figure S1B and data not
shown). While no apparent phenotypic changes were observed
in Rosa26Sox2/Sox2 or KRT5-CreER;Rosa26Sox2/+ (heterozygous)
compound mutants 6 months after three Tamoxifen injec-
tions (data not shown), Sox2 overexpression in KRT5-CreER;
Rosa26Sox2/Sox2 (homozygous) mutants disrupts epithelial struc-
ture within 6 weeks (Figure 2C). Basal cell populations (Sox2 and
p63 double positive) in both the esophagus and forestomach are
expanded (Figure 2D) and proliferating cells (phosphorylated
Histone H3 positive) are present in the upper layers of the epithe-
lium (Figure 2E). The proliferation index for the esophageal
epithelium increases 2.3-fold after Sox2 overexpression (Fig-
ure S1C), and this correlates with increased expression of the
cell-cycle protein Cyclin D1 (Figure S1D). When cultured in the
3D system, these Sox2 overexpressing progenitor cells form
larger spheres than wild-type controls (Figure S1E). Moreover,
Sox2 overexpression inhibits the differentiation of basal progen-
itor cells into squamous epithelium in the esophagus and forest-
omach, leading to the presence of patches of undifferentiated
cells (Figures 2F and S1F).
Although epithelial hyperplasia is initially seen in both the
esophagus and forestomach after Sox2 overexpression, further
pathological progression to SCC was observed only in the for-
estomach (n = 34; Figures 3A and 3B) (Table S1). Severe skin
lesions were also noticed in the KRT5-CreER;Rosa26Sox2/Sox2
mutants and necessitated euthanasia of the animals. When
Sox2 overexpression was induced by only two doses of Tamox-
ifen, the skin lesions were less severe. While no tumors were
found in the esophagus over 30 weeks, multiple SCC nodules
(n R 4) containing GFP+ve and p63+ve cells developed in the
forestomach within 13 weeks (Figures 3A–3H) (Table S1). Signif-
icantly, the cells invade into themuscularis externa in 14 out of 23
mice that have tumors at week 13 (Figures 3E and 3F) and 3 out
of 3 at week 30 (Table S1), confirming their tumorigenic pheno-
type. Multiple invasive SCC nodules also develop in the skin at
week 30 (Figure S2A).ell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc. 307
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Figure 4. Tumor Initiation in the Forestom-
ach Involves Inflammatory Signaling after
Sox2 Overexpression
(A) Progressive accumulation of neutrophils
(Ly6c+) and macrophages (F4/80+) in the epithe-
lium and mesenchyme of the hyperplastic forest-
omach. Two injections of Tamoxifen were used to
induce Sox2 overexpression. While a small
number of neutrophils and macrophages are
present in the mesenchyme at day 14, extensive
infiltration of inflammatory cells appears in the
damaged epithelium at day 28 and day 42.
(B) Quantitative real-time RT-PCR (n = 3) analysis
shows increased transcript levels of IL-1b and
IL-6 in the hyperplastic tissues after Sox2 over-
expression. Data are represented as mean ± SEM.
(C) p-Stat3 levels are increased in the nuclei of the
hyperplasic and invading SCC epithelium in the
mutants, as indicated by immunostaining. Note
that tumor cells invade into themuscle layer, which
is positive for smooth muscle actin staining
(arrows).
(D) Inhibition of inflammation with serial injections
of Dexamethasone in the hyperplastic forest-
omach after Sox2 overexpression. Note that the
levels of IL-6 and p-Stat3 are decreased upon
Dexamethasone injections.
(E) Inhibition of Stat3 signaling with serial injections
of the Stat3 inhibitor WP1066 in the hyperplastic
forestomach. Note that Stat3 phosphorylation
has largely been suppressed by the inhibitor in the
epithelium and mesenchyme of the forestomach
harvested 2 days after the final injection. Abbre-
viations: SMA, smooth muscle actin; Dex, Dexa-
methasone. Scale bar represents 50 mm. See also
Figure S2 and Tables S2, S3, and S4.
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Sox2 and Stat3 Cotransform Foregut ProgenitorsTaken together, these results reveal that Sox2 overexpression
in basal progenitor cells promotes proliferation and inhibits
differentiation in both the esophagus and forestomach. Signifi-
cantly, Sox2 overexpression induces invasive SCC formation
only in the forestomach, suggesting that either region-specific
intrinsic differences in tumor susceptibility or microenviron-
mental factors are important for the malignant transformation
of Sox2 overexpressing progenitor cells.
Inflammation with IL-6/Stat3 Pathway Activation
Facilitates Tumor Formation in the Forestomach of the
KRT5-CreER;Rosa26Sox2/Sox2 Mice
We next investigated why SCC only develops in the forestomach
after Sox2 overexpression and not in the esophagus. When
retrospectively examining pathological progression, we ob-
served small numbers of neutrophils and macrophages in the
mesenchyme of the forestomach 2 weeks after Sox2 overex-
pression. As hyperplasia develops 4–6 weeks after Sox2 induc-308 Cell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc.tion, the inflammatory cells progressively
accumulate in both the mesenchyme
and epithelium (Figure 4A). This appears
to correlate with the loss of differentiated
cells and exposure of progenitor cells to
the bile acid-rich environment in the
stomach. Significantly, such inflamma-tion never occurs in the esophagus at any time examined (Fig-
ure S2B). We then compared gene expression between the
hyperplastic forestomach and the normal tissue of KRT5-CreER
controls (n = 3 for each) 6 weeks after Sox2 induction by micro-
array analysis. Transcript levels of the endogenous Rosa26
gene in the mutants decreased 14.2-fold, as expected from
recombination (Table S2). This is consistent with the overex-
pression of Sox2 protein, as validated by immunostaining
(Figures 2F and S1F). Of the 84 genes significantly upregulated
(p < 0.05, fold change R 1.5) upon Sox2 overexpression
(Table S3), many are associated with tissue damage and inflam-
mation, including S100A8 (227-fold), Ccl20 (21-fold), Cxcr3
(17-fold), and IL-1b (9-fold) (Table S4). The increase of IL-1b tran-
script levels was validated with independently prepared RNAs
using quantitative real-time RT-PCR (Figure 4B). Although the
microarray data showed no significant change, qPCR detected
a 2.8-fold increase in IL-6 transcript levels in the hyperplastic
epithelia (Figure 4B) and this upregulation was confirmed by
Cell Stem Cell
Sox2 and Stat3 Cotransform Foregut Progenitorsimmunohistochemistry (Figure 4D, middle). These findings
corroborate previous observations that overexpression of IL-1b
in glandular stomach tissue is accompanied by increased levels
of IL-6 (Quante et al., 2012; Tu et al., 2008). Interestingly, when
FACS-sorted Sox2 overexpressing forestomach and esopha-
geal cells (GFP+ve) were cultured in the presence of 10 ng/ml
IL-6, the cells around the periphery of the esophageospheres
became protrusive and irregular and correlated with decreased
levels of E-Cadherin (Figure S2C and data not shown), suggest-
ing that IL-6-mediated signaling promotes invasiveness of Sox2
overexpressing progenitor cells.
IL-6 is a potent activator of the Janus kinase (Jak)/Stat3
signaling pathway, which is involved in tumor formation in
several tissues, including the forestomach (Stairs et al., 2011).
Consistently, we found that p-Stat3 levels are increased in the
hyperplastic forestomach epithelium 6 weeks after Tamoxifen
injection and the total protein level of Stat3 is also moderately
increased upon Sox2 overexpression (Figure S2D). Immuno-
staining further confirmed that p-Stat3 is enriched in the nuclei
of hyperplastic forestomach epithelium (Figure 4C) and that
this expression pattern is maintained in invasive SCC tumor cells
(Figure 4C). Of note is that we did not observe a similar increase
in nuclear p-Stat3 in the esophagi of the same mice in which
either forestomach hyperplasia or tumor was found (data not
shown).
To test whether inflammation after Sox2 overexpression is
important for tumor initiation in the forestomach, we injected
the immunosuppressant Dexamethasone after Sox2 induction
(Figure 4D). Serial Dexamethasone treatment reduces the
inflammatory reaction in the hyperplastic forestomach and also
dampens the accumulation of IL-6 and nuclear localization of
p-Stat3 in the epithelial layers (Figures 4D and S2E). More impor-
tantly, Dexamethasone treatment dramatically reduces tumor
incidence (1/8 versus 6/8, p < 0.01) when examined at 13 weeks
after Sox2 overexpression (Figure S2F). Similarly, when phos-
phorylation of Stat3 is inhibited with a specific inhibitor
WP1066 (Iwamaru et al., 2007), tumor incidence is also
decreased (1/9 versus 8/11, p < 0.01) (Figures 4E and S2G).
These findings support a model in which some unique feature
of the forestomach microenvironment, for example, exposure
to acid secreted by the hindstomach as previously shown
(Quante et al., 2012), leads to inflammation when combined
with the disruption of epithelial integrity caused by Sox2 overex-
pression. Moreover, this inflammation, mediated through the
IL-1b/IL-6/Stat3 pathway, is required for the malignant transfor-
mation of basal progenitor cells.
Activated Stat3 and Sox2 Synergistically Transforms
Mouse andHumanEsophageal Basal Progenitor, but Not
Differentiated Suprabasal Cells
Unlike in the mouse, the human esophagus is immediately
adjacent to the acid-producing stomach and the formation of
human esophageal SCC has recently been linked to acid reflux
from this organ (Pandeya et al., 2010; Uno et al., 2011). Although
our findings demonstrate that microenvironment-activated
inflammation and Stat3 are important for the malignant transfor-
mation of basal progenitor cells, it is also possible that intrinsic
differences between esophagus and forestomach contribute to
the contrasting tumor susceptibility after Sox2 overexpression.CWe therefore asked whether a combination of Sox2 and
activated Stat3 is capable of transforming basal progenitor
cells of the mouse esophagus. Sox2-overexpressing basal
progenitor cells (GFP+ve) from the esophagi of KRT5-CreER;
Rosa26Sox2/Sox2mice were isolated and infected with a constitu-
tively activated Stat3 (Stat3C) lentivirus (Figures 5A and 5B).
These cells were then injected into the flanks of the immunode-
ficient NOD/SCID gamma (NSG) mice (1 3 106 cells/injection).
No tumor was observed in mice injected with esophageal basal
cells overexpressing either Sox2 or Stat3C alone (three mice for
each group). In contrast, progenitors co-overexpressing Sox2
and Stat3C give rise to SCCs (GFP+ve) within a 5 week observa-
tion period in all of the threemice (Figures 5C and 5D). The exper-
iment was repeated once and the same results were obtained.
The tumor cells express p63, indicating their basal progenitor
cell identity, and proliferating cells (pH3+ve) are present in the
tumor mass (Figure 5E). We have also isolated and co-overex-
pressed Sox2 and Stat3 in the differentiated suprabasal cells
(p75 negative), but no tumor formation was observed from inject-
ing these cells into three NSG mice (13 106 cells/injection) after
a 5 week observation period.
We next asked whether the combined overexpression of Sox2
and activated Stat3 can similarly transform human esophageal
epithelial cells. We used EPC2, an immortalized human esopha-
geal epithelial cell line. EPC2 cells express moderate levels of
Sox2 and p63 (Figure S3A) and can proliferate and differentiate
to form stratified epithelium in 3D organotypic culture (Andl
et al., 2003; Okawa et al., 2007). When embedded in extracellular
matrix, single EPC2 cells are also able to self-renew to form
spheres (Figure S3B), suggesting EPC2 cells maintain some
progenitor cell functions. EPC2 cells infected with lentivirus
harboring Sox2-IRES-GFP and Stat3C have a higher sphere-
forming efficiency than control cells that overexpress either
Sox2-IRES-GFP or Stat3C alone (9.2% for co-overexpression,
6.4% and 7.8% for Sox2 and Stat3C overexpression alone,
respectively; Figures 5F and 5G). When 1 3 106 cells were in-
jected into NSG mice, none of the control groups (three mice
per group) induced tumor formation. In contrast, prominent
tumor masses (GFP+ve) were observed in three out of three
mice injected with EPC2 cells co-overexpressing Sox2 and
Stat3C (Figures 5G–5I). Histological analysis indicates that they
are invasive squamous cell cancer (Figure 5J). As expected,
the nuclei of the tumor cells express high levels of Sox2 and
moderate levels of p63 (Figures 5K and 5L).
Together, these findings demonstrate that high levels of Sox2
and activated Stat3 are able to transform basal progenitor cells
but not the differentiated suprabasal cells isolated from the
mouse esophagus. Moreover, the combination of these two
transcription factors can also malignantly transform human
esophageal progenitor-like cells, leading to squamous cell carci-
noma when implanted into immunodeficient mice.
shRNA-Mediated Knockdown of STAT3 and SOX2
Reduces the Growth of Mouse and Human Squamous
Cancer Cells
High levels of Sox2 are needed for maintaining breast and brain
cancer stemcells (tumor initiating cells) and tumor growth (Gang-
emi et al., 2009; Leis et al., 2012). To test whether Sox2 is simi-
larly required for the maintenance of SCC, we isolated tumorell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc. 309
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Figure 5. Co-overexpression of Sox2 and
Constitutively Activated Stat3 Leads to
Malignant Transformation of Mouse Esoph-
ageal Basal Progenitors and Human Esoph-
ageal Progenitor-like EPC2 Cells
(A) Schematic of the experimental procedure for
the transformation of Sox2-overexpressing esoph-
ageal basal progenitor cells with Stat3C lentivirus.
(B) Representative colony of Sox2 overexpressing
(GFP+ve) esophageal basal progenitor cells in-
fected with Stat3C lentivirus. Basal progenitor
cells were isolated from the esophagus of the
KRT5-CreER;Rosa26Sox2/Sox2 mice after four
doses of Tamoxifen.
(C) Representative GFP+ve tumors developed in
the immunodeficient NSG mice after injecting
Sox2 and Stat3C co-overexpressing mouse
esophageal basal progenitor cells.
(D) Tumors initiated by Sox2 and Stat3C co-over-
expressing basal progenitor cells are squamous
cell carcinomas, as indicated by H&E staining.
(E) Tumor cells express basal progenitor marker
p63 and some of tumor cells are at proliferative
state (phosphorylated Histone H3+ve).
(F) EPC2 cells transformed with Sox2-IRES-eGFP
and Stat3C express GFP as visualized with
immunofluorescence microscopy.
(G) Sox2 and Stat3C co-overexpressing EPC2
cells form spheres with high levels of GFP as
visualized with immunofluorescence microscopy.
(H and I) Representative GFP-positive tumors form
in the NSG mice after inoculation of Sox2 and
Stat3C co-overexpressing EPC2 cells. Two
representative tumors formed by the transformed
EPC2 cells are shown (H). The tumor is positive for
GFP under the fluorescent microscope (I).
(J) H&E staining to show that tumors initiated by
Sox2 and Stat3C co-overexpressing EPC2 cells
are squamous cell carcinomas.
(K) Tumor cells express high levels of Sox2 in the
nuclei.
(L) Tumor cells express the basal progenitor cell
marker p63. Scale bar represents 3 mm in (C), (H),
and (I) and 50 mm in (D), (E), (G), (J), and (L). See
also Figure S3.
Cell Stem Cell
Sox2 and Stat3 Cotransform Foregut Progenitorscells from the forestomach of the KRT5-CreER;Rosa26Sox2/Sox2
mice and performed Sox2 knockdown with a lentivirus-based
system. Sox2 knockdown reduces the size of the tumor spheres
formed in the 3D culture system and is accompanied by an
increased number of apoptotic cells (Figures 6A and S4A). Simi-
larly, Stat3 knockdown also reduces the size of the tumor
spheres (Figures 6A and S4A). When injected into NSG mice
(1 3 106 cells/injection), the tumors formed by the Sox2 or
Stat3 knockdown cells are apparently smaller than those formed
by the nonknockdown tumor cells (0.31 ± 0.078 g [Sox2 knock-
down], 0.24 ± 0.046 g [Stat3 knockdown], and 0.66 ± 0.070 g
[nonknockdown control], n = 6 for each group, Figure 6B). The
weight difference of Sox2 knockdown versus control or Stat3
knockdown versus control is significant (p < 0.05).
A previous study has shown that SOX2 knockdown reduces
the proliferation of the nontumorigenic esophageal SCC line
TE10 (Bass et al., 2009). SOX2 knockdown using the same
system inhibits proliferation in the tumorigenic esophageal
SCC line KYSE450 and leads to small esophageospheres310 Cell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc.(Figures 6C, 6D, and S4B). Sox2 knockdown also increases
the number of apoptotic cells within the esophageospheres
(Figure S4B). Similarly, shRNA-mediated STAT3 knockdown
also reduces the proliferation and increases the apoptosis of
KYSE450 cells (Figures 6C, 6D, and S4B) and combined
knockdown of SOX2 and STAT3 leads to a further decrease
in cell proliferation (Figures 6C and 6D). Moreover, individual
knockdown of SOX2 and STAT3 in KYSE450 cells leads to
smaller tumors than in mock controls (Figure 6E) and combined
knockdown of SOX2 and STAT3 further reduces xenograft
weight in NSG mice (Figure 6E). In aggregate, individual or
combined knockdown of SOX2 and STAT3 in a tumorigenic
esophageal SCC cell line reduces cell proliferation and tumor
growth when injected into NSG mice.
Increased Protein Levels of p-STAT3 and SOX2
Correlate with a Poor Prognosis for Human ESCC
Upregulated SOX2 expression is associated with poor differenti-
ation of esophageal SCC in human patients (Gen et al., 2010). In
Figure 6. shRNA-Mediated Knockdown of
Sox2 and Stat3 Reduces the Proliferation
ofMouse Forestomach andHuman Esopha-
geal Squamous Cancer Cells
(A) Lentiviral shRNA knockdown of Sox2 or Stat3
increases the number of apoptotic cells and
reduces the size of spheres formed by mouse
forestomach squamous cancer cells.
(B) Knockdown of Sox2 or Stat3 in forestomach
cancer cells significantly reduces tumor weight
after injection into immunodeficient NSG mice.
Control is a representative tumor generated
by forestomach cancer cells infected with virus
containing scramble controls (n = 6 for each
group, p < 0.01), and data are represented as
mean ± SEM.
(C and D) Lentiviral shRNA knockdown of SOX2,
STAT3, or both reduces the proliferation of
KYSE450 cells. The proliferating cells are indi-
cated by the phosphorylated Histone H3 (pH3)
immunostaining (C). Cell numbers in (D) were
calculated by the average of cells in three wells
for each group, and data are represented as
mean ± SEM.
(E) Knockdown of SOX2, STAT3, or both in
KYSE450 cells significantly reduces tumor weight
after injection into immunodeficient NSG mice.
Control is a representative tumor generated by
KYSE450 cells infected with virus containing
scramble controls (n = 6 for each group, p < 0.01),
and data are represented as mean ± SEM. Scale
bar represents 50 mm. See also Figure S4.
Cell Stem Cell
Sox2 and Stat3 Cotransform Foregut Progenitorsthe human esophagus, SOX2 protein is highly enriched in basal
progenitor cells that express p75 (Figures 7A and 7B) and 8%
of basal cells are positive for p-STAT3 (Figure 7C, also see Fig-
ure S5). Through immunohistochemical examination of 83
primary human esophageal SCC samples (from 74 male and 9
females, refer to Tables S5 and S6 for other clinical parameters),
we found that 45 (54.2%) and 38 (45.8%) samples are positive for
SOX2 and p-STAT3 staining, respectively. Interestingly, 31
(37.3%) samples are positive for both SOX2 and p-STAT3
(Figures 7D–7F). High levels of p-STAT3 andSOX2 in esophageal
SCC correlate with a poor 5 year survival as compared to SOX2
positive only group (14.3% versus 42.9%, p < 0.01) (Figure 7G).
Of note is that patients with high levels of STAT3, including the
STAT3 and SOX2 double-positive group, have a worse prog-
nosis than STAT3-negative patients (11.6% versus 37.1%, p <
0.05). Taken together, these results suggest that a simultaneous
increase in SOX2 and p-STAT3 protein levels serves as a marker
of poor prognosis for patients with esophageal SCC.
DISCUSSION
It has been proposed that mutations accumulated in stem/
progenitor cells can have catastrophic consequences for tissue
integrity and homeostasis over the long term compared with
mutations in cell populations committed to terminal differentia-
tion (Barker et al., 2009; Visvader and Lindeman, 2012). In this
study, we provide genetic evidence that links basal progenitor
cells with the etiology of squamous cell carcinoma in the foregut.
We identify a mechanism by which the transcription factor Sox2Ccooperates with inflammation to transform basal progenitor cells
and initiate invasive squamous cell carcinoma (Figure 7I).
Stem/progenitor cells are located in the basal layer of the
stratified epithelium in the esophagus (Kalabis et al., 2008; Seery
and Watt, 2000). A recent study combining lineage tracing and
mathematic modeling suggests that the stratified esophageal
epithelium is maintained by a single type of basal stem/progen-
itor cell (Doupe´ et al., 2012). The progenitor marker we use here,
p75, has previously been used to isolate mouse tracheal basal
progenitor cells and human esophageal progenitor cells (Oku-
mura et al., 2003; Rock et al., 2009). Our immunostaining results
confirm that like Sox2 and Krt5, p75 is expressed in all basal
progenitors in the mouse and human esophagus. Purified
p75+ve mouse basal progenitor cells form large colonies of cells
in monolayer culture that continue to express the basal cell
markers Sox2 and p63. When grown in matrix, single progenitor
cells can proliferate to form spheres and the undifferentiated
cells can regenerate spheres when dissociated and re-
embedded, a property that has also been observed in progenitor
cells isolated from the trachea and neural tissue (Reynolds and
Weiss, 1992; Rock et al., 2009). Upon addition of serum, progen-
itor cells in the center of the sphere differentiate into squamous
cells. Our lineage-tracing results using KRT5-CreER are consis-
tent with previous findings using the Sox2-CreER mouse line
(Arnold et al., 2011), confirming that basal cells are progenitor
cells for the maintenance of the esophageal and forestomach
epithelium. We recently established a new Sox2-CreER
‘‘knockin’’ mouse line to confirm that Sox2+ve basal progenitor
cells self-renew and differentiate to maintain the epithelium.ell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc. 311
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Figure 7. High Levels of SOX2 and p-STAT3 Are Associated with a Poor Prognosis of Human ESCC and Model Figure
(A) SOX2 is enriched in basal cells, and LORICRIN is expressed in differentiated suprabasal cells of human esophageal biopsies.
(B) Basal cells are labeled by p75.
(C) p-STAT3 is colocalized with SOX2 in 8% of basal cells (arrowheads). Refer to Figure S5 for individual fluorescent channels.
(D–F) Representative ESCC sample that has high levels of SOX2 (D) and p-STAT3 (E). (F) shows overlapping view of the two individual fluorescent channels.
(G) High levels of p-STAT3 in SOX2+ve esophageal SCCs predict a poor 5 year survival rate. Overall survival curves were plotted according to the Kaplan-Meier
method, and p value was calculated using log rank test.
(H) Schematic of the squamous-columnar junction that separates the squamous (green) and columnar (white) tissues in the human and mouse upper gastro-
intestinal tract. Bile acid can cross the junction and induce injuries under pathological conditions.
(I) Schematic in which Sox2 overexpression cooperates with inflammation-activated Stat3 to malignantly transform basal progenitor cells. (Ia) Sox2 is expressed
in the basal progenitor cells of the normal esophagus and forestomach. (Ib) Sox2 overexpression expands basal progenitor cells by promoting proliferation and
inhibiting differentiation. (Ic) Bile acid reflux induces injury and inflammation in the expanded Sox2+ve progenitor cells. (Id) Sox2 and inflammation-activated Stat3
cooperate to transform basal progenitor cells and initiate invasive esophageal SCC. Inhibition of inflammation or Stat3 signaling reduces tumor incidence. Note
that the top keratin layer is absent in the human esophagus. Abbreviations: Lor, Loricrin; SCJ, squamous-columnar junction; BA, bile acid; Eso, esophagus; Fst,
forestomach; Hst, hindstomach; Duo, duodenum; BM, basement membrane. Scale bar represents 50 mm. See also Figure S5 and Tables S5 and S6.
Cell Stem Cell
Sox2 and Stat3 Cotransform Foregut Progenitors(See Figure S1G for lineage-tracing results. The details of this
mouse line will be described elsewhere.) Similar to the findings
by Arnold et al. (2011), ablation of basal cells disrupts tissue
integrity of the esophagus and forestomach in the Sox2-CreER;
Rosa26DTA mice (Figure S1H), confirming that basal cells are
stem/progenitor cells required for tissue maintenance.
Genomic amplification and protein overexpression of SOX2
has been identified in SCCs of several human tissues including
the lung, oral cavity, and esophagus (Bass et al., 2009; Freier
et al., 2010; Gen et al., 2010). We have provided direct evidence
that Sox2 overexpression promotes the proliferation of basal312 Cell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc.progenitor cells in both the esophagus and forestomach.
Notably, when Sox2 is overexpressed in the differentiated
suprabasal cells of the esophagus and forestomach using the
Krt10-Cre mouse line, the proliferation status in these cells
remains unchanged and no tumor formation is observed (J.Q.,
unpublished data), suggesting that the ability to promote cell
proliferation by Sox2 overexpression is specific to progenitor
cells. This concept is further supported by our evidence that
a combination of Sox2 and Stat3C overexpression can only
transform esophageal basal progenitor cells but not the differen-
tiated suprabasal cells (discussed below).
Cell Stem Cell
Sox2 and Stat3 Cotransform Foregut ProgenitorsWe found that increased levels of Sox2 are unable to transform
progenitor cells in the esophagus, while tumor formation in the
forestomach requires cooperation with inflammatory signaling
that can be suppressed by Dexamethasone. In the mouse, the
forestomach is in direct continuity with the hindstomach, which
secretes acid, while the esophagus is protected by a sphincter.
The acidic forestomach environment presumably injures the
hyperplastic epithelium, which contains regions of undifferenti-
ated progenitor cells and reduced levels of Loricrin after Sox2
overexpression. This is followed by inflammation and increased
levels of cytokines IL-1b and IL-6. In the human, there is no ker-
atinized forestomach expressing Sox2 and the esophagus is
also protected by a sphincter (Figure 7H). However, bile acid
may reach this tissue from the bile duct or stomach as a result
of gastroesophageal reflux (Figure 7H), a disorder affecting
30% of normal populations. In either case, exposure to bile
acid is associated with pathological changes and even malig-
nancy. Although it is bile acid-mediated injury that is more
commonly associated with the pathobiology of adenocarcinoma
(Souza, 2010), recent studies suggest that acid reflux also
increases the risk of esophageal SCC (Pandeya et al., 2010;
Uno et al., 2011). Our previous study showed that acid refluxate
disrupts epithelial integrity accompanied by Adam10-mediated
E-Cadherin cleavage in human biopsies. Conditional deletion
of E-cadherin in the mouse forestomach leads to a leaky epithe-
lium and basal cell hyperplasia (Jovov et al., 2011). In addition,
bile acid reflux precipitates inflammation and promotes the
incidence of SCC after carcinogen treatment in the esophagus
and forestomach in animal models that have undergone esoph-
ageoduodenal anastomosis surgery (Chen et al., 2007; Hao
et al., 2009). Our current study provides further evidence that
inflammatory signaling is required for malignant transformation
of basal progenitor cells and that inhibition of inflammation
with Dexamethasone reduces tumor incidence.
Stat3 is a key player in mediating inflammation-driven tumor-
igenesis in multiple gastrointestinal organs (Corcoran et al.,
2011; Grivennikov et al., 2009; Quante et al., 2012; Stairs et al.,
2011). Activation of Stat3 through inflammatory cytokines in
mouse models has been implicated in the development of
esophageal cancers, including SCC and adenocarcinoma
(Quante et al., 2012; Stairs et al., 2011). However, there is no
direct evidence that activated Stat3 drives esophageal tumor
initiation. Overexpression of Stat3C with the KRT5 promoter
induces hyperproliferation of epidermal epithelium but not tumor
formation in KRT5-Stat3C transgenic mice (Chan et al., 2008).
Although Stat3C overexpression transforms immortalized
mouse fibroblasts (Bromberg et al., 1999), we found that Stat3C
overexpression alone is unable to transform mouse esophageal
progenitors or immortalized human EPC2 esophageal progen-
itor-like cell line and requires the cooperation of Sox2 overex-
pression to generate tumorigenic cells. Sox2 and Stat3 are
essential components of the core circuitry that regulates self-
renewal of mouse embryonic stem cells. Studies combining
chromatin immunoprecipitation (ChIP) with genomic sequencing
demonstrate that Stat3 and Sox2 along with other pluripotency
transcription factors are probably clustered in multiple transcrip-
tion factor-binding loci (MTL), where they coregulate common
targets (Chen et al., 2008). Our data also suggest that Sox2
and Stat3 cooperate in the transformation of basal progenitorCcells and that disruption of this cooperation with a specific
Stat3 inhibitor reduces tumor incidence.
In summary, we provide multiple lines of evidence supporting
the idea that Sox2/Krt5/p75-positive basal progenitor cells in
the esophagus and forestomach are able to self-renew and
differentiate and that ectopic Sox2 overexpression promotes
the expansion of the progenitor pool. Furthermore, Sox2 cooper-
ates with inflammation signaling to transform progenitor cells
and leads to the formation of SCC. In clinical samples, increased
levels of SOX2 and p-STAT3 correlate with a poor 5 year survival
rate. Perturbing SOX2 and STAT3 expression reduces the
proliferation and survival of tumorigenic esophageal SCC cells
both in vitro and in a xenograft model. Cooperative oncogenic
lesions malignantly transform cells by modulating downstream
gene expression and signaling circuitry (Hanahan andWeinberg,
2000; McMurray et al., 2008). Identifying these target genes
in Sox2 and Stat3 co-overexpressing esophageal progenitor
cells will provide further insights into the pathobiology and
new therapeutic avenues for more effective treatment of esoph-
ageal cancer.EXPERIMENTAL PROCEDURES
Cell Isolation for the Mouse Esophagus and Forestomach Tumor
and FACS Analysis
Muscle layers were stripped off the mouse esophagus and the remaining
tissue was incubated in Dispase (BD Biosciences, 16 U/ml) in PBS (30 min)
at room temperature. Digestion was stopped by addition of Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 5% fetal bovine serum (FBS). Epithelium
was peeled off with forceps, cut into small pieces, and incubated in 0.1%
trypsin, 1.6 mM EDTA for 20 min at 37C. Digestion was stopped with 5%
FBS-containing medium followed by gentle pipetting and passage through
a 40 mm cell strainer. Similarly, forestomach tumor tissues were cut into small
pieces and digested with Trypsin but followed by passing through a syringe
with 21G needle for three times and then by passing through a strainer. For
FACS with p75 antibody, cells were diluted to 1 3 106 cells/ml in 2% FBS,
2% BSA in PBS, and incubated in 18 mg/ml rabbit anti-mouse p75 antibody
(1:100) or IgG isotype control followed by washing and incubation in allophy-
cocyanin-conjugated or Alexa Fluor 488 donkey anti-rabbit antibody (1:500,
Jackson ImmunoResearch Laboratories). Cells were then washed with
DMEM + 2% BSA and propidium iodide added to a final concentration of
200 ng/ml before sorting. GFP-positive cells were also sorted from the esoph-
agus and forestomach of the Sox2-GFP or KRT5-CreER;Rosa26Sox2/Sox2mice
following the previously described protocol (Rock et al., 2009). Cell sorting was
performed on FACS Vantage SE or FACS Aria II and data analyzed with FACS
Diva (BD Biosciences). Cells were collected in DMEM with 2% BSA and
cultured immediately.
Cell Culture and Sphere Culture
FACS-sorted mouse basal progenitor or forestomach tumor cells were plated
onto rat type IV collagen (BD Biosciences)-coated tissue culture dishes in
MTEC/Plus containing 20 ng/ml Egf and Fgf2 (Que et al., 2009). Human esoph-
ageal SCC cell line KYSE450 was kindly provided by Dr. Yutaka Shimada at
Kyoto University and maintained in 10% FBS RPMI medium. The EPC2 cell
line was hTERT immortalized with functionally intact p53 and p16 and main-
tained as previously described (Okawa et al., 2007).
FACS-sorted mouse esophageal, human EPC2, or KYSE450 cells were
resuspended in MTEC/Plus containing 20 ng/ml Egf and Fgf2, mixed 1:1
with growth factor-reduced Matrigel (BD Biosciences), and pipetted into
a 12-well 0.4 mm Transwell insert (Falcon). MTEC/Plus medium (1 ml) was
added to the lower chamber and refreshed every other day. For esophageo-
sphere-reforming assay, cell balls were collected and incubated in 0.25%
Trypsine with EDTA (GIBCO) for 12 min at 37C to dissociate into single cells
and then replated in the matrix. For the formation of spheres using sortedell Stem Cell 12, 304–315, March 7, 2013 ª2013 Elsevier Inc. 313
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Sox2 and Stat3 Cotransform Foregut ProgenitorsKRT5-CreER;Rosa26Sox2/Sox2 forestomach tumor or KYSE450 cells, drug-
selected scramble control, Sox2, or Stat3 knockdown cells were dispersed
into single cells and cultured with same matrix and medium. All cultures
were maintained at 37C, 5% CO2. For inducing differentiation, 5% FBS was
added to MTEC medium from day 1 in culture. To use IL-6 to treat the esoph-
ageospheres formed by FACS-sorted Sox2-overexpressing esophageal or
forestomach epithelium, we initially cultured cells for 8 days to form spheres,
and then we maintained the culture for another 5 days in the presence of
10 ng/ml IL-6. Whole-mount fluorescent pictures were taken with Leica
DMI3000 inverted microscope. Samples were fixed in 4% paraformaldehyde
in PBS, embedded in 3% UltraPure low-melting point agarose and then
paraffin, and were sectioned.
Statistical Analysis
Data are expressed as mean ± SD or mean ± SEM (for tumor weight). Differ-
ences between two samples were analyzed by Student’s t test. p values of
0.05 or less were considered statistically significant. Differences among three
or more groups were analyzed using ANOVA (SAS 9.2 version, SAS Institute).
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